Indegene Expands European Presence with New Entity in Spain

Indegene already has a strong presence in Europe, with operational centers in the UK, Germany, Ireland, and Switzerland.

Indegene, a Bengaluru-based digital-first life sciences commercialization company, has established a new entity in Spain, marking a significant step in its strategic expansion across Europe.

This move aligns with the company’s goal of helping life sciences organizations accelerate AI-driven innovation and future-proof their operations.

The newly launched Spanish entity will function as a key delivery hub for Indegene’s Europe-based clients, focusing on driving hyper-personalization and enhancing the experience of healthcare professionals (HCPs) and patients.

The company is actively strengthening its existing employee base in Spain with expanded capabilities in medical affairs, data and analytics, creative design, engineering, digital marketing, and customer experience.

Spain as a Growing Hub for Life Sciences Innovation

Highlighting Spain’s importance, Manish Gupta, Chairman and CEO of Indegene, said, “Growing R&D investments, a thriving life sciences innovation ecosystem, and a high-quality talent pool make Spain a vital market and talent hub for life sciences companies in Europe. With our new entity in Spain, we can co-innovate and collaborate much better with clients, helping them use data and AI more effectively to modernize commercialization processes and fast-track business transformation.”

Indegene already has a strong presence in Europe, with operational centers in the UK, Germany, Ireland, and Switzerland.

The company has made several acquisitions in recent years to bolster its European footprint. In 2023, Indegene acquired Trilogy Writing & Consulting GmbH, a provider of specialized medical writing services across clinical, regulatory, safety, and medical content.

In 2019, the company acquired DT Associates (now DT Consulting), a UK-based consulting firm supporting healthcare and life sciences clients.

These acquisitions have enabled Indegene to offer comprehensive support to leading life sciences companies across the commercialization value chain.

Blending Healthcare Expertise with Advanced Technology

Indegene combines deep healthcare expertise with a digital-first approach to assist pharma, biotech, and medical device companies in commercializing their products.

The company prides itself on fostering interdisciplinary collaboration, where medical doctors and data scientists work side by side to tackle complex challenges in life sciences.

More than 20% of its employees come from a medical education background, working closely with approximately 600 technologists specializing in AI, machine learning (ML), and other advanced technologies.

With 6 operational hubs and 18 offices across North America, Europe, and Asia, Indegene supports a diverse client base, including the world’s top 20 biopharma companies, emerging biotech firms, and medical device companies.

The company employs over 5,000 professionals worldwide, emphasizing its capability to scale operations and meet the evolving needs of the global life sciences sector.

Stay tuned for more such updates on Digital Health News.